Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 2
2017 1
2018 2
2019 8
2020 5
2021 13
2022 8
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
New Frontiers on ER Stress Modulation: Are TRP Channels the Leading Actors?
Vestuto V, Di Sarno V, Musella S, Di Dona G, Moltedo O, Gomez-Monterrey IM, Bertamino A, Ostacolo C, Campiglia P, Ciaglia T. Vestuto V, et al. Among authors: di sarno v. Int J Mol Sci. 2022 Dec 22;24(1):185. doi: 10.3390/ijms24010185. Int J Mol Sci. 2022. PMID: 36613628 Free PMC article. Review.
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity.
Musella S, Carotenuto L, Iraci N, Baroli G, Ciaglia T, Nappi P, Basilicata MG, Salviati E, Barrese V, Vestuto V, Pignataro G, Pepe G, Sommella E, Di Sarno V, Manfra M, Campiglia P, Gomez-Monterrey I, Bertamino A, Taglialatela M, Ostacolo C, Miceli F. Musella S, et al. Among authors: di sarno v. J Med Chem. 2022 Aug 25;65(16):11340-11364. doi: 10.1021/acs.jmedchem.2c00911. Epub 2022 Aug 16. J Med Chem. 2022. PMID: 35972998 Free PMC article.
Therapeutic potential of TRPM8 antagonists in prostate cancer.
Di Donato M, Ostacolo C, Giovannelli P, Di Sarno V, Monterrey IMG, Campiglia P, Migliaccio A, Bertamino A, Castoria G. Di Donato M, et al. Among authors: di sarno v. Sci Rep. 2021 Dec 1;11(1):23232. doi: 10.1038/s41598-021-02675-4. Sci Rep. 2021. PMID: 34853378 Free PMC article.
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models.
Di Sarno V, Giovannelli P, Medina-Peris A, Ciaglia T, Di Donato M, Musella S, Lauro G, Vestuto V, Smaldone G, Di Matteo F, Bifulco G, Castoria G, Migliaccio A, Fernandez-Carvajal A, Campiglia P, Gomez-Monterrey I, Ostacolo C, Bertamino A. Di Sarno V, et al. Eur J Med Chem. 2022 Aug 5;238:114435. doi: 10.1016/j.ejmech.2022.114435. Epub 2022 May 12. Eur J Med Chem. 2022. PMID: 35598411
New 1,2,4-Oxadiazole Nortopsentin Derivatives with Cytotoxic Activity.
Cascioferro S, Attanzio A, Di Sarno V, Musella S, Tesoriere L, Cirrincione G, Diana P, Parrino B. Cascioferro S, et al. Among authors: di sarno v. Mar Drugs. 2019 Jan 8;17(1):35. doi: 10.3390/md17010035. Mar Drugs. 2019. PMID: 30626057 Free PMC article.
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis.
Musella S, D'Avino D, Peltner LK, Di Sarno V, Cerqua I, Merciai F, Vestuto V, Ciaglia T, Smaldone G, Di Matteo F, Di Micco S, Napolitano V, Bifulco G, Pepe G, Sommella EM, Basilicata MG, Aquino G, Gomez-Monterrey IM, Campiglia P, Ostacolo C, Roviezzo F, Werz O, Rossi A, Bertamino A. Musella S, et al. Among authors: di sarno v. J Med Chem. 2023 Jul 13;66(13):9201-9222. doi: 10.1021/acs.jmedchem.3c00831. Epub 2023 Jun 19. J Med Chem. 2023. PMID: 37334504 Free PMC article.
39 results